Medtronic (NYSE:MDT) announced today that a study using its continuous rhythm monitoring device showed AFib’s relationship with ischemic stroke. Fridley, Minnesota–based Medtronic’s data covers 466,635 patients included in the Optum unidentified electronic health record (EHR) and Medtronic CareLink databases. Findings were published online in JAMA Cardiology, according to a news release. Of the large population of […]
Cardiovascular
Welcome to MassDevice's Cardiovascular Hub, your resource for the latest news in cardiac implants, structural heart, heart valves, stents and more. Stay informed about the innovations and business news shaping the cardiovascular device industry.
🫀 Narrow your focus with these categories:
Cardiac Implants | Structural Heart | Pulsed-Field Ablation
Here are top cardiology features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ LVADs save lives: So why aren’t more available?
+ How Medtronic uses nitinol to improve the structure and effectiveness of heart devices
+ How Abbott designed the world’s first dual-chamber leadless pacemaker system
+ J&J used RWE for expanded indications — and you can, too
+ 7 cardiology startups you need to know
Latest Cardiology News
Haemonetics wins FDA nod for same-day discharge following AFib ablation using Vascade MVP
Haemonetics today said that it has received FDA approval for same-day discharge after atrial fibrillation ablation using its Vascade MVP venous vascular closure system. Vascade MVP is a vascular closure system that is designed for procedures that require multiple access site venous closures. It uses 6 to 12 Fr inner diameter sheaths that are commonly […]
GE Healthcare unveils next-gen cardiac-dedicated nuclear scanner
GE Healthcare (NYSE:GE) today announced that it has launched its MyoSpect cardiac-dedicated nuclear scanner. Chicago-based GE Healthcare designed the scanner to have an extended field-of-view processing with a new automated workflow. It features the company’s Alcyone technology and a CZT module design for a view of cardiac anatomy and pathology. “Today, the need for healthcare innovation […]
Boston Scientific to invest more than $30M in Irish facility
Boston Scientific (NYSE:BSX) will invest €30 million (about $34 million) in its Cork, Ireland facility, the Irish government announced today. The Irish government supported the research, development and innovation (RD&I) investment through IDA Ireland. The money will go toward accelerating the development and manufacturing of minimally-invasive medical technologies that treat patients suffering from cancer and […]
Abbott wins FDA approval for next-gen Amplatzer Talisman
Abbott (NYSE:ABT) announced today that the FDA has approved its Amplatzer Talisman PFO occlusion system for stroke prevention. In addition, the FDA cleared the Amplatzer Talisman delivery sheath. The Amplatzer Talisman is a next-generation version of the company’s Amplatzer PFO occluder, originally approved in 2016. The Talisman has an additional 30 mm device size, and […]
Women may have more adverse events with left atrial appendage occlusion devices than men
Women appear more likely than men to experience adverse events or lengthened hospital stays from left atrial appendage occlusion (LAAO) devices, the FDA announced today. In a letter to health care providers, the FDA said researchers have yet to determine the reason for the difference — and that it is working with device makers to […]
MedAlliance completes trial enrollment for sirolimus-eluting balloon for treating PAD
MedAlliance announced today that it completed patient enrollment for a trial of its Selution SLR sirolimus drug-eluting balloon. Geneva, Switzerland-based MedAlliance, along with Japanese partner MDK Medical, completed the enrollment following the acceptance of a Clinical Trial Notification (CTN) by the Pharmaceutical Products and Medical Devices Agency (PMDA) of Japan in June 2020. Get the full […]
FDA approves Baxter’s norepinephrine injection for treating low blood pressure
Baxter (NYSE:BAX) announced today that it received FDA approval for its premix norepinephrine bitartrate in 5% dextrose injection. Deerfield, Illinois-based Baxter launched the norepinephrine injection following the approval for raising blood pressure in adult patients with severe, acute hypotension (low blood pressure). Get the full story at our sister site, Drug Delivery Business News.
FDA approves Abbott’s next-gen Epic Plus heart valves
Abbott (NYSE:ABT) announced today that it received FDA approval for its Epic Plus and Epic Plus Supra stented tissue valves. The approval offers improved therapy options for people with aortic or mitral valve disease through the next-generation devices that build off of Abbott’s Epic surgical valve platform, according to a news release. Epic Plus, a […]
Nuwellis wins CE mark for 24-hour blood circuit set for use with Aquadex SmartFlow
Nuwellis (NSDQ:NUWE) announced today that it received CE mark approval for its 24-hour blood circuit set for use with the Aquadex SmartFlow. Eden Prairie, Minnesota-based Nuwellis — formerly CHF Solutions — can now market the 24-hour blood circuit set (UF 500-24 Hour) in the European Union and other locations that recognize the CE mark. According […]
Abbott enters U.S. TAVR market with FDA approval of its Portico with FlexNav
Abbott (NYSE:ABT) today announced U.S. FDA approval of its Portico with FlexNav TAVR system. The approval launches Abbott into a U.S. TAVR space that Edwards Lifesciences and Medtronic have dominated. (Check out our recent DeviceTalks Weekly podcast that recounted Edwards Lifesciences’ pioneering work in the space.) Boston Scientific is out of the TAVR market for […]